AC Immune (ACIU) EPS (Basic) Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.29% |
| Jun 30, 2025 | 4.66% |
| Mar 31, 2025 | 6.67% |
| Dec 31, 2024 | 68.96% |
| Sep 30, 2024 | 30.99% |
| Jun 30, 2024 | 6.01% |
| Mar 31, 2024 | 7.32% |
| Dec 31, 2023 | 39.55% |
| Sep 30, 2023 | 12.04% |
| Jun 30, 2023 | 5.12% |
| Mar 31, 2023 | -29.93% |
| Dec 31, 2022 | 6.61% |
| Jun 30, 2022 | 99.24% |
| Dec 31, 2021 | 0.03% |
| Dec 31, 2020 | -76.42% |
| Sep 30, 2020 | 57.20% |
| Jun 30, 2020 | 57.62% |
| Mar 31, 2020 | 70.11% |
| Dec 31, 2019 | -48.58% |
| Sep 30, 2019 | 14,030.85% |
| Jun 30, 2019 | -8,067.34% |
| Dec 31, 2018 | -22.66% |